31![XENICAL® (ORLISTAT) FOR HYPERCHOLESTEROLEMIA MEDICATIONS CRITERIA Pharmacology: Orlistat: Reverse lipase inhibitor that acts by inhibiting the absorption of dietary fats. Medication: XENICAL® (ORLISTAT) FOR HYPERCHOLESTEROLEMIA MEDICATIONS CRITERIA Pharmacology: Orlistat: Reverse lipase inhibitor that acts by inhibiting the absorption of dietary fats. Medication:](https://www.pdfsearch.io/img/e2a7543be56de3853d1a4f45a51c8df6.jpg) | Add to Reading ListSource URL: www.nhhealthyfamilies.comLanguage: English - Date: 2014-09-11 16:49:00
|
---|
32![HMG-CoA Reductase Inhibitors (atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, pitavastatin, rosuvastatin) and safety the risk of new onset diabetes/impaired glucose metabolism Agreed by PhVWP March 2012 HMG-CoA Reductase Inhibitors (atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, pitavastatin, rosuvastatin) and safety the risk of new onset diabetes/impaired glucose metabolism Agreed by PhVWP March 2012](https://www.pdfsearch.io/img/ff9b83315bc3a1f5acadd3f911923bd1.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2012-04-03 07:14:37
|
---|
33![Microsoft Word - PRAVACHOL_E_PIL_11 Jan 2013_APP_DIST.doc Microsoft Word - PRAVACHOL_E_PIL_11 Jan 2013_APP_DIST.doc](https://www.pdfsearch.io/img/9fac4497bea75dffe7f981fee110627c.jpg) | Add to Reading ListSource URL: www.bmscanada.caLanguage: English - Date: 2013-01-25 11:26:25
|
---|
34![Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index](https://www.pdfsearch.io/img/2281349c418874aad69388a9099daf09.jpg) | Add to Reading ListSource URL: www.health.gov.on.caLanguage: English - Date: 2014-11-18 09:36:10
|
---|
35![Microsoft Word - CMDh-PhVWP-006-Rev0_2009 11 Microsoft Word - CMDh-PhVWP-006-Rev0_2009 11](https://www.pdfsearch.io/img/0e709a26ee027856cce66be42e0f9c1f.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2009-11-26 06:38:20
|
---|
36![Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)](https://www.pdfsearch.io/img/d80669a905be73c15c4c679be8906231.jpg) | Add to Reading ListSource URL: health.mo.govLanguage: English - Date: 2009-02-03 16:51:10
|
---|
37![Endocrinologic and Metabolic Drugs Advisory Committee VYTORIN / ZETIA NDAs[removed]and[removed]James P. Smith, MD, MS Division of Metabolism and Endocrinology Products Endocrinologic and Metabolic Drugs Advisory Committee VYTORIN / ZETIA NDAs[removed]and[removed]James P. Smith, MD, MS Division of Metabolism and Endocrinology Products](https://www.pdfsearch.io/img/153518297112acf85fef247e52577951.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
38![Microsoft Word - PRAVACHOL_E_PM_11 Jan 2013_APP_DIST_CLN.doc Microsoft Word - PRAVACHOL_E_PM_11 Jan 2013_APP_DIST_CLN.doc](https://www.pdfsearch.io/img/f72edff7a163f9bad3b8e24a3a4f8a1a.jpg) | Add to Reading ListSource URL: www.bmscanada.caLanguage: English - Date: 2013-01-25 11:24:03
|
---|
39![[removed]VYTORIN ® [removed]EZETIMIBE 10 MG/SIMVASTATIN 10 MG TABLETS) VYTORIN ® 10/20 [removed]VYTORIN ® [removed]EZETIMIBE 10 MG/SIMVASTATIN 10 MG TABLETS) VYTORIN ® 10/20](https://www.pdfsearch.io/img/3d44a535b757d363aad56a9a4f81cf34.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:10:08
|
---|
40![3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMG) Deficiency (metabolic condition: organic acid disorder) Also known as: • HMG-CoA lyase deficiency 3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMG) Deficiency (metabolic condition: organic acid disorder) Also known as: • HMG-CoA lyase deficiency](https://www.pdfsearch.io/img/9ec5b3497770555148d1a7eaae60f13d.jpg) | Add to Reading ListSource URL: www.albertahealthservices.caLanguage: English - Date: 2013-09-16 18:32:42
|
---|